Results from the REVISIT trial show aztreonam-avibactam had similar cure rates as meropenem in patients with serious ...

The protection also held across different strains, for people in their 70s, and for those with underlying medical conditions.

GSK said Wednesday that it is paying up to $2.2 billion to resolve 93% of its US state-based liability cases related to its ...

RSV vaccines have reportedly fallen since U.S. regulators narrowed the recommended age range and frequency for the shots.

Air Products (APD) shares rise 1.5% as activist investor Mantle Ridge set to meet with executives, all directors to join ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

On a similar front, 3% of U.S. high school students surveyed in 2023 identified as transgender, and 25% of transgender ...

Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...

October is RSV Awareness Month and GSK’s Dr. Leonard Friedland is here to tell you what you need to know about this ...

The vaccine demonstrated efficacy across different respiratory syncytial virus (RSV) subtypes in older adults between the ...

This year's prestigious Nobel Prize in Chemistry has been awarded to David Baker, the director of the Institute for Protein ...

GSK shared new Phase III data on Arexvy, its RSV vaccine, at the 2024 CHEST annual meeting. Results show a single dose of ...